Literature DB >> 2506031

In vitro activity of cefpodoxime, a new oral cephalosporin.

E E Stobberingh1, A W Houben, J H Philips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2506031     DOI： 10.1007/bf01968153

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Authors:  Y Utsui; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

2.  Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.

Authors:  C C Knapp; J Sierra-Madero; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.

Authors:  E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790
  3 in total
  4 in total

1.  Microbiological evaluation of cefpodoxime proxetil.

Authors:  B Wiedemann; E Luhmer; M T Zühlsdorf
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 2.  Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.

Authors:  B Fulton; C M Perry
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.

Authors:  H Knothe; P M Shah; O Eckardt
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

Review 4.  Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  J E Frampton; R N Brogden; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.